Blunting of AICAR-induced human skeletal muscle glucose uptake in type 2 diabetes is dependent on age rather than diabetic status
Authors:
- John Andree BabrajJohn Andree Babraj
- Kristy MustardKMKristy Mustard
- Calum SutherlandCSCalum Sutherland
- Mhari C. TowlerMTMhari C. Towler
- Shaui ChenSCShaui Chen
- Kenneth SmithKSKenneth Smith
- Kevin GreenKGKevin Green
- Graham LeeseGLGraham Leese
- David Grahame HardieDHDavid Grahame Hardie
- Michael J. RennieMRMichael J. Rennie
- Daniel James CuthbertsonDCDaniel James Cuthbertson
Open Access
- 1 May 2009
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 296 (5) , E1042-E1048
Abstract
We demonstrated previously that, in healthy young men, 5-aminoimidazole-4-carboxamide 1-β-d-ribofuranoside (AICAR) stimulates human muscle 2-deoxyglucose (2DG) uptake without detectable activation of muscle AMP-activated protein kinase (AMPK) but with extracellular-regulated kinase 1/2 (ERK1/2) activation. We tested whether AICAR stimulates muscle 2DG uptake in healthy older patients with or without type 2 diabetes (T2D). Six healthy young subjects (23 ± 3 yr, BMI 25 ± 2 kg/m−2; means ± SE), eight older subjects (59 ± 4 yr, BMI 28 ± 2 kg/m−2), and eight subjects with T2D (62 ± 4 yr, BMI 27 ± 2 kg/m−2) received a 6-h 2DG infusion (prime 10 mg/kg, 6 mg·kg−1·h−1) and AICAR (10 or 20 mg·kg−1·h−1) from 3 to 6 h. Quadriceps biopsies were taken at 0, 3, and 6 h. We determined 1) 2DG uptake, 2) total AMPKα activity, AMPK, acetyl-CoA carboxylase (ACC), and AS160 phosphorylation, and 3) ERK1/2 phosphorylation. Ten milligrams per kilogram per hour AICAR increased 2DG uptake by 2.9 ± 0.7-fold in young men ( P < 0.001), 1.8 ± 0.2-fold in older men ( P < 0.01), and 1.6 ± 0.1-fold in men with T2D; 20 mg·kg−1·h−1 AICAR increases were 2.5 ± 0.1-fold (older men, P < 0.001) and 2.2 ± 0.2-fold (men with T2D, P < 0.001). At 3-h AMPK activity and AMPK, ACC and AS160 phosphorylation were unchanged, but ERK1/2 phosphorylation increased at both AICAR doses. The fold changes of ERK1/2 phosphorylation and 2DG uptake closely correlated ( R2 = 0.55, P = 0.003). AICAR stimulates muscle 2DG uptake in T2D to the same extent as in healthy age-matched controls, but there is an age-related reduction.Keywords
This publication has 30 references indexed in Scilit:
- Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKαExperimental & Molecular Medicine, 2007
- Activation of AMP kinase α1 subunit induces aortic vasorelaxation in miceThe Journal of Physiology, 2007
- Effect of Acute Exercise on AMPK Signaling in Skeletal Muscle of Subjects With Type 2 DiabetesDiabetes, 2007
- Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individualsAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Influence of patella alta on knee extensor mechanicsJournal of Biomechanics, 2005
- Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscleThe FASEB Journal, 2004
- AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetesAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Effects of Age and Body Fat Insulin Resistance in Healthy MenDiabetes Care, 1993
- AICA‐Riboside: Safety, Tolerance, and Pharmacokinetics of a Novel Adenosine‐Regulating AgentThe Journal of Clinical Pharmacology, 1991
- Effects of aging on glucose-mediated glucose disposal and glucose transport.Journal of Clinical Investigation, 1986